News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
716,390 Results
Type
Article (43864)
Company Profile (362)
Press Release (672164)
Section
Business (212190)
Career Advice (2088)
Deals (36437)
Drug Delivery (95)
Drug Development (82367)
Employer Resources (172)
FDA (16732)
Job Trends (15321)
News (356630)
Policy (33466)
Tag
Academia (2702)
Alliances (52336)
Alzheimer's disease (1282)
Approvals (16658)
Artificial intelligence (151)
Bankruptcy (357)
Best Places to Work (11872)
Biotechnology (258)
Breast cancer (124)
Cancer (1124)
Cardiovascular disease (100)
Career advice (1745)
Cell therapy (252)
Clinical research (65250)
Collaboration (407)
Compensation (203)
COVID-19 (2639)
C-suite (101)
Data (1143)
Diabetes (153)
Diagnostics (6418)
Earnings (86536)
Employer resources (151)
Events (114385)
Executive appointments (321)
FDA (17285)
Funding (370)
Gene therapy (191)
GLP-1 (596)
Government (4462)
Healthcare (19450)
Infectious disease (2727)
Inflammatory bowel disease (110)
Interviews (323)
IPO (16660)
Job creations (3829)
Job search strategy (1493)
Layoffs (429)
Legal (8082)
Lung cancer (178)
Manufacturing (183)
Medical device (13927)
Medtech (13932)
Mergers & acquisitions (19859)
Metabolic disorders (412)
Neuroscience (1564)
NextGen Class of 2024 (6860)
Non-profit (4637)
Northern California (1503)
Obesity (236)
Opinion (194)
Patents (108)
People (58685)
Phase I (20411)
Phase II (28710)
Phase III (21364)
Pipeline (462)
Postmarket research (2582)
Preclinical (8764)
Radiopharmaceuticals (254)
Rare diseases (228)
Real estate (6251)
Regulatory (22231)
Research institute (2475)
Resumes & cover letters (360)
Southern California (1326)
Startups (3849)
United States (13935)
Vaccines (583)
Weight loss (175)
Date
Today (83)
Last 7 days (689)
Last 30 days (3807)
Last 365 days (36892)
2024 (33844)
2023 (41303)
2022 (52541)
2021 (57172)
2020 (55794)
2019 (48569)
2018 (36569)
2017 (33657)
2016 (33260)
2015 (39464)
2014 (33059)
2013 (28096)
2012 (30338)
2011 (30934)
2010 (28886)
Location
Africa (759)
Arizona (203)
Asia (39931)
Australia (6644)
California (3411)
Canada (1303)
China (258)
Colorado (153)
Connecticut (164)
Europe (87417)
Florida (465)
Georgia (124)
Illinois (364)
Indiana (202)
Kansas (99)
Maryland (592)
Massachusetts (2696)
Michigan (174)
Minnesota (283)
New Jersey (980)
New York (983)
North Carolina (752)
Northern California (1503)
Ohio (141)
Pennsylvania (860)
South America (1155)
Southern California (1326)
Texas (478)
Utah (95)
Washington State (375)
716,390 Results for "accelerated technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OneCell Diagnostics, Inc. Announces Oversubscribed Series A Funding Round to Accelerate Proprietary Cell Biopsy Technology to Democratize Precision Oncology
November 21, 2024
·
4 min read
FDA
5 Accelerated Approvals Gone Wrong
Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market. However, recent years have seen a number of high-profile market withdrawals and failed confirmatory trials.
October 14, 2024
·
7 min read
·
Heather McKenzie
Press Releases
Inspire Medical Systems, Inc. Announces $75 million Accelerated Share Repurchase Program
November 11, 2024
·
6 min read
Press Releases
Quantum-Si to Develop Acceleration Platform and Advance Core Technologies in Collaboration with NVIDIA
November 20, 2024
·
5 min read
Pharm Country
Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced plans to accelerate its development initiatives in obesity and cardiometabolic disease through the acquisition of the assets of Better Therapeutics, Inc.
May 22, 2024
·
7 min read
Business
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
bioAffinity Technologies, Inc. today announced David Elzi, Ph.D., has been named Vice President of Product Development to accelerate the development of new diagnostics based on the proprietary technology platform behind CyPath® Lung, the Company’s commercial test for the detection of early-stage lung cancer.
April 24, 2024
·
6 min read
Lone Star Bio
bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung
bioAffinity Technologies, Inc. reported accelerating growth of 375% in CyPath® Lung tests ordered and processed over the past three months as compared to the previous three months.
March 5, 2024
·
5 min read
Press Releases
Ellison Institute of Technology Los Angeles Accelerates Cancer Research with Sapio LIMS
October 23, 2024
·
3 min read
FDA
Evolving FDA Accelerated Approval Pathway Suffers Spate of Withdrawals
As therapies for rare and neurological diseases earn accelerated approval, experts laud the program’s intent while remaining concerned about confirmatory trials and clinical efficacy, especially as products greenlit under this pathway are pulled from the market.
October 28, 2024
·
7 min read
·
Heather McKenzie
Business
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
bioAffinity Technologies, Inc., a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, reported financial results for the three months ended March 31, 2024.
May 15, 2024
·
10 min read
1 of 71,639
Next
